2018-Patient Advocates

Media | Gallery | Contact

Media | Gallery | Contact

Home / 2018 SABCS^® / 2018-Patient Advocates

Registration Categories & Fees
Patient Advocate Mentor Sessions
Financial Assistance
Advocate Program

2018-Patient Advocates

SABCS^® welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

Registration Category & Fees

The patient advocate registration category is reserved exclusively for patient advocates and is not intended for medical professionals. Individuals interested in registering under this category either work or volunteer for national not-for-profit patient advocacy organizations that demonstrate a charitable mission, engage in patient advocacy activities, provide support for people with cancer, have a nonprofessional membership, do not offer CME or scientific programs for professionals.

Individuals registered under this category are not eligible to receive continuing education credit for their attendance.

For advocate program information and possible financial assistance contact:
Alamo Breast Cancer Foundation
PO Box 780067
San Antonio, TX 78278

Email: sandistanford@alamobreastcancer.org

Category	Price
Until 10/31/18	$150.00
Beginning 11/1/18	$225.00

Pre-registration discount ends October 31, 2018
Pre-registration closes November 16, 2018
On site registration opens December 3, 2018

Patient Advocate Mentor Sessions

The Alamo Breast Cancer Foundation runs a grassroots advocacy program to eradicate the presence of breast cancer in our society.

Every year, Alamo Breast Cancer Foundation sponsors special mentoring sessions for patient advocates at SABCS^®. These usually take place 6 PM – 8 PM on Wednesday, Thursday & Friday during the symposium.

Leading experts in the field of breast cancer provide commentary on symposium presentations and responding to advocates’ questions about the relevance of this scientific data.

Click here to view the 2018 Hot Topic Mentor Sessions.

Financial Assistance

Every year the Alamo Breast Cancer Foundation provides scholarships for eligible breast cancer advocates to attend the annual San Antonio Breast Cancer Symposium^®, and take part in Mentor Sessions.

Website
Information regarding the 2018 ABCF Advocate Program can be found at
www.alamobreastcancer.org. This page also includes a link to an on line application.

E-Mail sandistanford@alamobreastcancer.org for information and an application. The application will be on Alamo Breast Cancer Foundation website during May of 2018

All applications for financial assistance must be submitted by 12:01 am on September 1, 2018.

Advocate Program

The 21st Annual Advocate Program is sponsored by Alamo Breast Cancer Foundation (ABCF), a non-profit 501[c]3 organization. This San Antonio-based grassroots advocacy, educational, and support organization was established for women and men with breast cancer and for those concerned about breast cancer issues. ABCF is active locally and nationally (as members of the National Breast Cancer Coalition) in their goal to eradicate breast cancer in our lifetime.

The 1st Annual Advocate Program was held in 1998, in conjunction with the 21st Annual San Antonio Breast Cancer Symposium^®, as an educational program specially designed to address the needs of patient advocates and those who support them. The program for 2018 will include Orientation, Dinner, Mentors Program, two Educational programs and Breast Cancer Update for the grant recipients. 30-40 travel grants are expected to be available for 2018, pending receipt of sufficient grant funds.

The administration of this program is handled entirely by Alamo Breast Cancer Foundation. Their 2018 proposal will be mailed to a select list, and we hope you will support their program in addition to the 2018 San Antonio Breast Cancer Symposium^®.

Contact Information:
Sandi Stanford
Alamo Breast Cancer Foundation
PO Box 780067
San Antonio, TX 78278
Email: sandistanford@alamobreastcancer.org
Website Address: www.alamobreastcancer.org

Year	Funding Sources	# Travel Grants Applications	# Travel Grants Awarded	Total # Advocate Registration to SABCS^®
1998	Glaxo Wellcome Eli Lilly Zeneca	14	14	82
1999	Bristol-Myers Genentech Wyeth-Ayerst	42	30	104
2000	Aventis Genentech AstraZeneca Glaxo Wellcome Pharmacia Oncology	62	50	123
2001	AstraZeneca Aventis Bristol-Meyers Squibb Chroma Vision Eli Lilly Genentech GlaxoSmithKline Pharmacia	52	36	118
2002	AstraZeneca Aventis Bristol-Myers Squibb ChromaVision DakoCytomation Eli Lilly Genentech GlaxoSmithKline Pharmacia	40	28	119
2003	AstraZeneca Pharmaceuticals Bristol Myers Squibb Chromavision DakoCytomation Eli Lilly & Co Genentech Genomic Health GlaxoSmithKline Pfizer	52	37	168
2004	AstraZeneca Pharmaceuticals DakoCytomatic, Inc. Genentech, Inc. Genomic Health, Inc. GlaxoSmithKline Introgen Therapeutics, Inc. Sanofi-Aventis	52	37	168
2005	AstraZeneca Pharmaceuticals Cytyc Eli Lilly & Company Genentech Genomic Health GlaxoSmithKline Introgen Therapeutics Sanofi-Aventis	49	32	201
2006	Avon Foundation NBCC Fund--Best Practices Award AstraZeneca Genentech Genomic Health Eli Lilly Sanofi-Aventis	109	43	199
2007	Abraxis Oncology AstraZeneca Avon Foundation Genentech GlaxoSmithKline Novartis Roche Introgen Therapeutics Sanofi-Aventis Dr. Sharon Wilks	109	42	233
2008	Abraxane-AZ AstraZeneca Avon Foundation Cytori Genentech BioOncology Genomic Health, Inc. GlaxoSmithKline Her2 Support Novartis Roche Sanofi-Aventis Dr. Sharon Wilks	34	32	225
2009	Abraxis BioOncology AstraZeneca Avon Foundation for Women Cytori Therapeutics, Inc Eli Lilly & Co Genentech Genomic Health, Inc GlaxoSmithKline Her2 Support Group Organization National Breast Cancer Coalition Novartis Pharmaceuticals Corp Sanofi-Aventis Dr. Sharon Wilks, MD, FACP Dr. Peter Ravdin, MD, PhD	82	36	235
2010	AACR Abraxis BioOncology Amgen AstraZeneca Avon Foundation for Women Eisai, Inc. Eli Lilly & Co. Genentech GlaxoSmithKline Novartis Pharmaceuticals Corporation Dr. Peter Ravdin, MD, PhD Sanofi-Aventis Dr Sharon Wilks, MD, FACP	107	32	297
2011	AACR Amgen Avon Foundation for Women Boehringer Ingelheim Genentech Genomic Health, Inc. GlaxoSmithKline Julie Ann Carpenter Memorial Fund Novartis Pharmaceuticals Corp Peter Ravdin, MD, PhD Sharon Wilks, MD, FACP Syndax	119	41	298
2012	AACR Amgen Avon Foundation for Women Celgene Corporation Genentech Genomic Health, Inc GlaxoSmithKline Julie Ann Carpenter Memorial Fund Nektar Novartis Pharmaceuticals Corp Peter Ravdin, MD, PhD	68	31	144
2013	AACR Amgen AstraZeneca Avon Foundation for Women Celgene Corporation Genentech Genomic Health Julie Ann Carpenter Memorial Fund Novartis Pharmaceuticals Peter Ravdin, MD, PhD SABCS^® Sharon Wilks, MD, FACP	61	23	171
2014	AACR Amgen AstraZeneca Avon Foundation for Women DARA BioSciences Eisai Genentech Genomic Health, Inc Julie Ann Carpenter Memorial Fund NanoString Technologies Nektar Therapeutics Novartis Pharmaceuticals Nuclea Diagnostics Peter Ravdin, MD, PhD Pfizer SABCS^® Syndax	78	28	229
2015	AACR Amgen Oncology AstraZeneca Pharmaceuticals Avon Foundation for Women Eisai Inc. Genentech BioOncology Genomic Health, Inc. Julie Ann Carpenter Memorial Fund NanoString Technologies Navidea Biopharmaceuticals Nektar Therapeutics Novartis Oncology Recycledman Foundation SABCS^® Susan G. Komen Syndax Pharmaceuticals	71	28	196
2016	AACR Amgen Oncology AstraZeneca Pharmaceuticals Avon Foundation for Women Biotheranostics, Inc. Cascadian Therapeutics Eisai Genentech BioOncology Genomic Health Julie Ann Carpenter Memorial Fund Lumicell M-3 Health Communications NanoString Technologies Nektar Therapeutics Novartis Oncology Pfizer The Recycledman Foundation Syndax Pharmaceuticals SABCS^® Susan G. Komen	63	34	180
2017	AACR Avon Foundation for Women Biotheranostics, Inc. The Joe W. and Dorothy Dorsett Brown Foundation Cascadian Therapeutics Eisai Genentech BioOncology Genomic Health Immunomedics Julie Ann Carpenter Memorial Fund Merck NanoString Technologies Nektar Therapeutics Novartis Oncology Pfizer, Inc. The Recycled Man Foundation Seno Medical Instruments, Inc. Syndax Pharmaceuticals, Inc.	73	31	222